TIGIT and neoplasm: Studies using flow cytometry, quantitative reverse-transcriptase PCR (qRT-PCR), and RNA-Seq for PD-1 expression evaluated NK cells in primary human tumor samples and demonstrated under various conditions that human and mouse NK cells consistently lack PD-1 expression, despite the significant upregulation of other regulatory markers, such as TIGIT [108].